Illustration: Annelise Capossela/Axios
The AI-powered drug discovery race is heating up, with tech giants and a wave of startups jockeying for partnerships with Big Pharma.
Why it matters: These partnerships could trigger faster development and more VC investment in budding AI drug discovery companies.
